Clinical trials
Phase 1 Marijuana Abuse trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
92 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 8 |
| 2017 | 7 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 2 |
| 2021 | 9 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Recruiting | 15 |
| Active, not recruiting | 8 |
| Not yet recruiting | 6 |
| Terminated | 6 |
| Withdrawn | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 26 |
| Johns Hopkins University | 16 |
| National Institute on Drug Abuse (NIDA) | 7 |
| University of California, Los Angeles | 7 |
| New York State Psychiatric Institute | 4 |
| Shanna Babalonis, PhD | 4 |
| Battelle Memorial Institute | 3 |
| University of California, San Diego | 3 |
| Aelis Farma | 2 |
| Hannah Harris | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Marijuana Abuse | 92 |
| Psychotic Disorders | 10 |
| Substance-Related Disorders | 10 |
| Pain | 9 |
| Mental Disorders | 3 |
| Opioid-Related Disorders | 3 |
| Cognitive Dysfunction | 2 |
| Schizophrenia | 2 |
| Tobacco Use Disorder | 2 |
| Agnosia | 1 |
Trials
Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.